NO985558L - Ny forbedret formulering for behandling av tromboembolisme - Google Patents

Ny forbedret formulering for behandling av tromboembolisme

Info

Publication number
NO985558L
NO985558L NO985558A NO985558A NO985558L NO 985558 L NO985558 L NO 985558L NO 985558 A NO985558 A NO 985558A NO 985558 A NO985558 A NO 985558A NO 985558 L NO985558 L NO 985558L
Authority
NO
Norway
Prior art keywords
treatment
thromboembolism
formulation
new improved
improved formulation
Prior art date
Application number
NO985558A
Other languages
English (en)
Norwegian (no)
Other versions
NO985558D0 (no
Inventor
Froth Jan-Erik L
Lennart Lindfors
Anna-Lena Ungell
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of NO985558D0 publication Critical patent/NO985558D0/no
Publication of NO985558L publication Critical patent/NO985558L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
NO985558A 1996-05-31 1998-11-27 Ny forbedret formulering for behandling av tromboembolisme NO985558L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602145A SE9602145D0 (sv) 1996-05-31 1996-05-31 New improved formulation for treatment of thromboembolism
PCT/SE1997/000914 WO1997045138A1 (en) 1996-05-31 1997-05-28 New improved formulation for treatment of thromboembolism

Publications (2)

Publication Number Publication Date
NO985558D0 NO985558D0 (no) 1998-11-27
NO985558L true NO985558L (no) 1998-11-27

Family

ID=20402816

Family Applications (1)

Application Number Title Priority Date Filing Date
NO985558A NO985558L (no) 1996-05-31 1998-11-27 Ny forbedret formulering for behandling av tromboembolisme

Country Status (14)

Country Link
US (1) US6673365B1 (de)
EP (1) EP1015022B1 (de)
JP (1) JP2000511526A (de)
AR (1) AR013569A1 (de)
AT (1) ATE284706T1 (de)
AU (1) AU722450B2 (de)
CA (1) CA2253410A1 (de)
DE (1) DE69731981T2 (de)
ID (1) ID19472A (de)
NO (1) NO985558L (de)
NZ (1) NZ332788A (de)
SE (1) SE9602145D0 (de)
WO (1) WO1997045138A1 (de)
ZA (1) ZA974386B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462021B1 (en) 2000-11-06 2002-10-08 Astrazeneca Ab Use of low molecular weight thrombin inhibitor
SE0203349D0 (sv) * 2002-11-12 2002-11-12 Astrazeneca Ab New use
WO2004050637A2 (en) 2002-12-03 2004-06-17 Axys Pharmaceuticals, Inc. 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4464175A (en) * 1982-08-25 1984-08-07 Altman Alan R Multipurpose tamponade and thrombosclerotherapy tube
AU1629383A (en) * 1982-10-02 1984-04-05 Amano Seiyaku K.K. Earthworm tissue protease thrombolytic agents
JPH07507565A (ja) * 1992-10-02 1995-08-24 ファイザー・インク． 非イオン性表面活性剤を含有する医薬組成物
SE9301916D0 (sv) * 1993-06-03 1993-06-03 Ab Astra New peptides derivatives
SE9302135D0 (sv) * 1993-06-18 1993-06-18 Kabi Pharmacia Ab New pharmaceutical composition
SE9404196D0 (sv) * 1994-12-02 1994-12-02 Astra Ab New antithrombotic formulation

Also Published As

Publication number Publication date
NZ332788A (en) 2000-05-26
AU3111597A (en) 1998-01-05
DE69731981T2 (de) 2005-12-22
NO985558D0 (no) 1998-11-27
CA2253410A1 (en) 1997-12-04
ZA974386B (en) 1997-12-01
US6673365B1 (en) 2004-01-06
ID19472A (id) 1998-07-16
WO1997045138A1 (en) 1997-12-04
ATE284706T1 (de) 2005-01-15
AU722450B2 (en) 2000-08-03
JP2000511526A (ja) 2000-09-05
AR013569A1 (es) 2001-01-10
EP1015022A1 (de) 2000-07-05
DE69731981D1 (de) 2005-01-20
EP1015022B1 (de) 2004-12-15
SE9602145D0 (sv) 1996-05-31

Similar Documents

Publication Publication Date Title
NO972475L (no) Ny antitrombotisk formulering, fremgangsmåte for dens fremstilling og anvendelse derav
NO994256D0 (no) SmÕ molekyler som er anvendelige ved behandling av inflamasjonssykdom
NO914217L (no) Sakkarinderivater nyttige som proteolytiske enzyminhibitorer og fremstilling derav
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
WO2002028434A3 (en) Use of a ppar delta activator for treating inflammatory conditions
EE03517B1 (et) ACE-inhibiitorite uus meditsiiniline kasutamine düspeptiliste sümptomite raviks
EE03804B1 (et) Karboanhüdraasi inhibiitorite kasutamine ravimi valmistamiseks, mis on ette nähtud kollatähni turseravimiseks
ATE190843T1 (de) Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten
NO985558L (no) Ny forbedret formulering for behandling av tromboembolisme
NO984920L (no) Preparater omfattende en nitronforbindelse for anvendelse ved behandling av okulµr inflammasjon
DK0871446T3 (da) Anvendelse af eliprodil til fremstilling af et lægemiddel til behandling af ischaemiske sygdomme i nethinden eller den optiske nerve
IS3577A7 (is) Aðferð til að sótthreinsa og um leið staðreyna árangur sótthreinsunarinnar, ásamt efni til þess
WO2001034546A3 (en) Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for the treatment of dry eye
WO2001089558A3 (en) Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
NO984189L (no) FremgangsmÕte for behandling av bipolar forstyrrelse
EE9700350A (et) COMT-inhibiitorite uus kasutamine ja diabeetiliste vaskulaarsete häirete ärahoidmise meetod
NO970185L (no) Anvendelse av (S)-adenosyl-L-metionin (SAMe) og dets fysiologisk kompatible salter for behandling av reperfusjonsskade utlöst av temporær-fokal-ischemi
DK0968174T3 (da) Optisk aktiv 2-aminotetralin, fremgangsmåde til dets fremstilling og farmaceutiske præparater indeholdende selv samme, effektiv til forebyggelse og behandling af septisk chok
ID27052A (id) Pengobatan arthritis dan keadaan-keadaan lain yang sekupa
RU96119673A (ru) Способ лечения болевого синдрома
ITMI922657A1 (it) Composizione terapeutica per uso rettale a base di flunisolide e/o dei relativi esteri per il trattamento di disordini intestinali a carattere infiammatorio
NO984190L (no) FremgangsmÕte for behandling av insomnia
BR0015424A (pt) Análogos de ácido hidroxieicosatetraenóico e, métodos de seu uso em tratamento de distúrbios de olho seco
EA199800698A1 (ru) Способ лечения и фармацевтическая композиция
UA38590A (uk) Спосіб лікування гломерулонефриту з анефротичним синдромом та гематуричним компонентом

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application